Senescence-messaging secretome: SMS-ing cellular stress
The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
Abstract
Oncogene-induced cellular senescence constitutes a strong anti-proliferative response, which can be set in motion following either oncogene activation or loss of tumour suppressor signalling. It serves to limit the expansion of early neoplastic cells and as such is a potent cancer-protective response to oncogenic events. Recently emerging evidence points to a crucial role in oncogene-induced cellular senescence for the 'senescence-messaging secretome' or SMS, setting the stage for cross-talk between senescent cells and their environment. How are such signals integrated into a coordinated response and what are the implications of this unexpected finding?
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, the SASP reinforces and spreads senescence in autocrine and paracrine fashions (Acosta et al., 2013; Coppe ´ et al., 2010; Kuilman and Peeper, 2009) and activates immune responses that eliminate senescent cells (Krizhanovsky et al., 2008a; Mun ˜ oz-Espı ´n and Serrano, 2014).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Kuilman and Peeper, 2009
In the citing paper
“Senescent cells secrete a plethora of factors, including pro-inflammatory cytokines and chemokines, growth modulators, angiogenic factors, and matrix metalloproteinases (MMPs), collectively termed the senescent associated secretory phenotype (SASP) or senescence messaging secretome (SMS) (Figure 1; Table 2) (Coppe ´ et al., 2010; Kuilman and Peeper, 2009).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Kuilman and Peeper, 2009
In the citing paper
“OIS or senescence induced by loss of a tumor suppressor was verified in vivo in human and murine preneoplastic lesions (Collado et al., 2005; Gorgoulis and Halazonetis, 2010; Kuilman and Peeper, 2009) and primary or treated neoplasias (Haugstetter et al., 2010).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Kuilman and Peeper, 2009
In the citing paper
“In most studies, senescence is assessed in ex vivo cultures or fresh samples by SAb -gal staining or indirect markers in formalin-fixed tissues”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Kuilman and Peeper, 2009
In the citing paper
“This SASP or senescence messaging secretome (SMS) (Kuilman and Peeper 2009) reflects the non-cell-autonomous functionality of senescent cells and may underpin their in vivo role in the pathophysiology of aging and age-related disorders.”
From Cellular senescence and its effector programs (2014) · cites this paper as Kuilman and Peeper 2009
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“OIS corresponds to a premature form of cellular senescenc”
BackgroundCellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Pleiotropy, natural selection, and the evolution of senescence.
Williams, G. C. (1957) · Evolution · doi:10.1111/j.1558-5646.1957.tb02911.x · Cited by 4,279
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473 · cited 1×
“For instance, in a mouse model of liver carcinoma driven by inducible shRNA-mediated depletion of p53 and HRAS V12 expression, Scott Lowe's laboratory showed that reactivation of p53 in the tumour results in a robust senescence respons”
BackgroundSenescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 1×
“OIS and replicative senescence share a number of characteristics, including an increase in senescence-associated β-galactosidase (SA-β-GAL) activity and the condensation of individual chromosomes into distinct heterochromatic bodies, called senescence-associated heterochromatic foci (SAHF”
BackgroundBRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Self-citation
Research works printed but not linked: 1
- Gagnon, A. M., Chabot, J., Pardasani, D. & Sorisky, A. Extracellular matrix induced by TGFβ impairs insulin signal transduction in 3T3-L1 preadipose cells. J. Cell Physiol. 175, 370–378 (1998). · doi:10.1002/(sici)1097-4652(199806)175:3<370::aid-jcp15>3.0.co;2-9
Cited by
Items 301–400 of 910
Molecular pathology endpoints useful for aging studies
Niedernhofer, L. J., Kirkland, J. L., & Ladiges, W. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.012 · Cited by 59
Borovski, T., Beke, P., van Tellingen, O., Rodermond, H. M., Verhoeff, J. J. C., Lascano, V., Daalhuisen, J. B., Medema, J. P., & Sprick, M. R. (2012) · Oncogene · doi:10.1038/onc.2012.172 · Cited by 67
Senescence and cancer: An evolving inflammatory paradox
Ruhland, M. K., Coussens, L. M., & Stewart, S. A. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.10.001 · Cited by 60
Epithelial cell senescence induces pulmonary fibrosis through Nanog-mediated fibroblast activation
Chen, X., Xu, H., Hou, J., Wang, H., Zheng, Y., Li, H., Cai, H., Han, X., & Dai, J. (2019) · Aging · doi:10.18632/aging.102613 · Cited by 69
Cho, J. H., Kim, M. J., Kim, K. J., & Kim, J.-R. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.142 · Cited by 59
“In addition to growth arrest, senescent cells show a variety of characteristic phenotypes including larger and flattened cell morphology,(2) increased activity of senescence-associated b-galactosidase (SA-bgal),(3) upregulation of p53 and p16 protein levels,(4) DNA damage markers, such as gH2AX and telomere dysfunctio…”
BackgroundCellular Senescence in Liver Disease and Regeneration
Ferreira-Gonzalez, S., Rodrigo-Torres, D., Gadd, V. L., & Forbes, S. J. (2021) · Seminars in Liver Disease · doi:10.1055/s-0040-1722262 · Cited by 59
IGFBP7 Is Not Required for B-RAF-Induced Melanocyte Senescence
Scurr, L. L., Pupo, G. M., Becker, T. M., Lai, K., Schrama, D., Haferkamp, S., Irvine, M., Scolyer, R. A., Mann, G. J., Becker, J. C., et al. (2010) · Cell · doi:10.1016/j.cell.2010.04.021 · Cited by 65
“Key components of the Wnt1, transforming growth factor b, plasmin, and interleukin signaling cascades reinforce senescence and potentially sensitize neighboring cells to proliferative arrest (reviewed in Acosta et al., 2008; Kuilman and Peeper, 2009).”
Sasaki, N., Itakura, Y., & Toyoda, M. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00533-w · Cited by 59
The Jekyll and Hyde of Cellular Senescence in Cancer
Demirci, D., Dayanc, B., Mazi, F. A., & Şentürk, Ş. (2021) · Cells · doi:10.3390/cells10020208 · Cited by 69
Hu, H., Zhao, R., He, Q., Cui, C., Song, J., Guo, X., Zang, N., Yang, M., Zou, Y., Yang, J., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202101988r · Cited by 62
Toba, H., & Lindsey, M. L. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.08.014 · Cited by 61
Cellular senescence: a double‐edged sword in the fight against cancer
Ohtani, N., Takahashi, A., Mann, D. J., & Hara, E. (2012) · Experimental Dermatology · doi:10.1111/j.1600-0625.2012.01493.x · Cited by 57
Epithelial proliferation and cell cycle dysregulation in kidney injury and disease
Lee, K., Gusella, G. L., & He, C. (2021) · Kidney International · doi:10.1016/j.kint.2021.03.024 · Cited by 60
Thrombospondin-1 mediates oncogenic Ras–induced senescence in premalignant lung tumors
Baek, K.-H., Bhang, D., Zaslavsky, A., Wang, L.-C., Vachani, A., Kim, C. F., Albelda, S. M., Evan, G. I., & Ryeom, S. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67465 · Cited by 57
Foersch, S., Sperka, T., Lindner, C., Taut, A., Rudolph, K. L., Breier, G., Boxberger, F., Rau, T. T., Hartmann, A., Stürzl, M., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.016 · Cited by 62
Hampl, V., Martin, C., Aigner, A. M., Höbel, S., Singer, S., Frank, N., Sarikas, A., Ebert, O., Prywes, R., Gudermann, T. W., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202406 · Cited by 70
“Amongst the SMS factors, the expression of the chemokine (C ‐”
InfluentialSenescence and tumor suppression
Hinds, P., & Pietruska, J. (2017) · F1000Research · doi:10.12688/f1000research.11671.1 · Cited by 57
Cellular senescence in osteoarthritis and anti-aging strategies
Hou, A., Chen, P., Tang, H., Meng, H., Cheng, X., Wang, Y., Zhang, Y., & Peng, J. C. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.08.002 · Cited by 60
Hubackova, S., Novakova, Z., Krejcikova, K., Kosar, M., Dobrovolna, J., Duskova, P., Hanzlikova, H., Vancurova, M., Barath, P., Bartek, J., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.15.12521 · Cited by 56
Wang, J., Feng, Y., Han, P., Wang, F., Luo, X., Liang, J., Sun, X., Ye, J., Lu, Y., & Sun, X. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0200-7 · Cited by 56
Effenberger, T., von der Heyde, J., Bartsch, K., Garbers, C., Schulze‐Osthoff, K., Chalaris, A., Murphy, G., Rose‐John, S., & Rabe, B. (2014) · The FASEB Journal · doi:10.1096/fj.14-254565 · Cited by 54
“Senescent cells remain metabolically active and secrete various cytokines, chemokines, and growth factors including interleukin (IL)-6, IL-8, growth-regulated protein (GRO ), and amphiregulin (3, 4).”
BackgroundRegulation of Senescence in Cancer and Aging
Kong, Y., Cui, H., Ramkumar, C., & Zhang, H. (2011) · Journal of Aging Research · doi:10.4061/2011/963172 · Cited by 68
Hu, X., & Zhang, H. (2019) · Medical Science Monitor · doi:10.12659/msm.914295 · Cited by 55
Senescence-Associated Secretory Phenotype as a Hinge Between Cardiovascular Diseases and Cancer
Banerjee, P., Kotla, S., Velatooru, L. R., Abe, R. J., Olmsted‐Davis, E. A., Cooke, J. P., Schadler, K., Deswal, A. M., Herrmann, J., Lin, S. H., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.763930 · Cited by 57
Enhanced killing of therapy‐induced senescent tumor cells by oncolytic measles vaccine viruses
Weiland, T., Lampe, J., Essmann, F., Venturelli, S., Berger, A., Bossow, S., Berchtold, S., Schulze‐Osthoff, K., Lauer, U. M., & Bitzer, M. (2014) · International Journal of Cancer · doi:10.1002/ijc.28350 · Cited by 55
“the secretion of a plethora of different factors, collectively called the senescence-messaging secretome or senescenceassociated secretory phenotype (SASP).(12) Although senescent cells undergo a permanent cell cycle arrest and loose their clonogenicity, they remain viable and metabolically active in vivo.”
BackgroundPerrigue, P. M., Silva, M. E., Warden, C. D., Feng, N. L., Reid, M. A., Mota, D. J., Joseph, L. P., Tian, Y. I., Glackin, C. A., Gutova, M., et al. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0268 · Cited by 55
“An important component of the cellular senescence program is the senescence-associated secretory phenotype (SASP), a group of secreted proteins that includes growth factors, inflammatory cytokines, and proteases (the senescence messaging secretome) (6,7).”
BackgroundWijayasiri, P., Astbury, S., Kaye, P., Oakley, F., Alexander, G. J., Kendall, T. J., & Aravinthan, A. D. (2022) · Cells · doi:10.3390/cells11142221 · Cited by 54
“These factors promote inflammation, which aids clearance of cell debris and encourages tissue repair and remodelling [1,4,9,24,25].”
BackgroundLong-Term Quiescent Fibroblast Cells Transit into Senescence
Marthandan, S., Priebe, S., Hemmerich, P., Klement, K., & Diekmann, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115597 · Cited by 54
“Thus, other cellular processes must be involved in senescence induction [49, 118] which must be active in nonreplicating quiescent cells also at low oxygen levels [119].”
BackgroundNF1 loss induces senescence during human melanocyte differentiation in an iPSC‐based model
Larribere, L., Wu, H., Novak, D., Galach, M., Bernhardt, M., Orouji, E., Weina, K., Knappe, N., Sachpekidis, C., Umansky, L., et al. (2015) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12369 · Cited by 54
“Furthermore, we measured the secretion of a panel of proinflammatory factors belonging to the senescenceassociated secretory phenotype (SASP) which was first described as a self-amplifying secretory network in senescent fibroblasts (Acosta et al., 2008; Kuilman and Peeper, 2009).”
BackgroundFang, Y., Medina, D., Stockwell, R., McFadden, S., Quinn, K., Peck, M. R., Bartke, A., Hascup, K. N., & Hascup, E. R. (2021) · doi:10.1101/2021.11.08.467509 · Cited by 53
Periodontal Disease and Senescent Cells: New Players for an Old Oral Health Problem?
Aquino-Martínez, R., Khosla, S., Farr, J. N., & Monroe, D. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207441 · Cited by 66
“space can be classified into soluble signals, insoluble proteins, and matrix-degrading factors, which are collectively known as SASP [16], or senescence-messaging secretome [38].”
BackgroundLong-term cardiovascular complications following sepsis: is senescence the missing link?
Merdji, H., Schini‐Kerth, V. B., Meziani, F., & Toti, F. (2021) · Annals of Intensive Care · doi:10.1186/s13613-021-00937-y · Cited by 66
“The shift to a SASP [54], also termed senescence-messaging secretome [55], is undoubtedly the most characteristic and relevant feature of senescent cells and a potential biomarker.”
Background(2023) · doi:10.1007/s11357-023-00843-0 · Cited by 53
“SASP includes proinflammatory cytokines, chemokines, growth factors, and proteases [8, 9] caused by chronic inflammation [9, 10], DNA damage [11], mitochondrial dysfunction [12], immune cell dysfunction [13], ROS generation [11, 14], and brain protein aggregation [15, 16]; all of which may be…”
BackgroundAnti-Aging Effects of Calorie Restriction (CR) and CR Mimetics Based on the Senoinflammation Concept
Kim, D. H., Bang, E., Jung, H. J., Noh, S. G., Yu, B. P., Choi, Y. J., & Chung, H. Y. (2020) · Nutrients · doi:10.3390/nu12020422 · Cited by 57
“Senescent cells have been shown to release multiple inflammatory cytokines and chemokines, which is defined as senescence-associated secretory phenotype (SASP) [7].”
BackgroundSCAMP4 enhances the senescent cell secretome
Kim, K. M., Noh, J. H., Bodogai, M., Martindale, J. L., Pandey, P. R., Yang, X., Biragyn, A., Abdelmohsen, K., & Gorospe, M. (2018) · Genes & Development · doi:10.1101/gad.313270.118 · Cited by 53
“…(senescenceassociated secretory phenotype), encompassing a broad spectrum of secreted proteins such as proinflammatory cytokines, lymphokines, growth factors, angiogenic factors, and matrix metalloproteases that comprise the senescent cell secretome (Kuilman and Peeper 2009; Coppé et al. 2010).”
BackgroundTranslating the Biology of Aging into New Therapeutics for Alzheimer's Disease: Senolytics
Riessland, M., & Orr, M. E. (2023) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2023.104 · Cited by 52
Redox-dependent and independent effects of thioredoxin interacting protein
Cao, X., He, W., Pang, Y., Cao, Y., & Qin, A. (2020) · Biological Chemistry · doi:10.1515/hsz-2020-0181 · Cited by 54
Role of Hyperglycemia in the Senescence of Mesenchymal Stem Cells
Yin, M., Zhang, Y., Yu, H., & Li, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.665412 · Cited by 55
“Both effects are essential for tissue or organ regeneration and reconstruction (Kuilman and Peeper, 2009).”
BackgroundAdem, Y., Galderisi, U., & Alessio, N. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1148761 · Cited by 57
“Moreover, senescence may promote wound healing (Campisi and D’adda Di Fagagna, 2007; Kuilman and Peeper, 2009).”
BackgroundCellular senescence induced by aberrant MAD2 levels impacts on paclitaxel responsiveness in vitro
Prencipe, M., Fitzpatrick, P., Gorman, S., Mosetto, M., Klinger, R., Furlong, F. M., Harrison, M. J., O’Connor, D. P., Roninson, I. B., O’Sullivan, J. M., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605419 · Cited by 53
“The induction of this form of cellular fate is biologically significant as senescent cells are able to modify their microenvironment by the secretion of transforming factors (Kuilman and Peeper, 2009; Young and Narita, 2009).”
BackgroundBeach, T. A., Johnston, C. J., Groves, A. M., Williams, J. P., & Finkelstein, J. N. (2017) · Experimental Lung Research · doi:10.1080/01902148.2017.1318975 · Cited by 55
Pituitary senescence: The evolving role of Pttg
Chesnokova, V., & Melmed, S. K. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.02.012 · Cited by 53
“New findings of the role of cytokines, and particular of IL-6 in OIS(Kuilman and Peeper, 2009), suggest the possible contribution of endogenous IL-6 in development of pituitary adenoma senescence, which, as well as its induction by aberrant intracellular PTTG levels, may explain the benign nature…”
BackgroundInfluentialChronic Inflammation Potentiates Kidney Aging
Mei, C., & Zheng, F. (2009) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2009.07.002 · Cited by 52
Mesenchymal stroma: primary determinant and therapeutic target for epithelial cancer
Goruppi, S., & Dotto, G. P. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.08.006 · Cited by 56
Sadaie, M., Dillon, C., Narita, M., Young, A. R. J., Cairney, C. J., Godwin, L. S., Torrance, C. J., Bennett, D. C., Keith, W. N., & Narita, M. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-01-0003 · Cited by 57
“Senescence markers include accumulation of senescence-associated β-galactosidase (SA-β-gal) activity, a persistent DNA-damage response, the senescence-associated secretory phenotype (SASP; Kuilman and Peeper, 2009; Coppé et al., 2010), and autophagy (Salama et al.”
BackgroundFerrand, M., Kirsh, O., Griveau, A., Vindrieux, D., Martin, N., Defossez, P.-A., & Bernard, D. (2015) · Aging · doi:10.18632/aging.100845 · Cited by 50
Liu, J., Zhao, Y. M., Ge, W., Zhang, P., Liu, X., Zhang, W., Hao, Y., Yu, S., Li, L., Chu, M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17349 · Cited by 50
NF90 coordinately represses the senescence-associated secretory phenotype
Tominaga-Yamanaka, K., Abdelmohsen, K., Martindale, J. L., Yang, X., Taub, D. D., & Gorospe, M. (2012) · Aging · doi:10.18632/aging.100497 · Cited by 49
“This trait of senescent cells has been termed senescence-associated secretory phenotype (SASP) or senescence messaging secretome (SMS) [4,5].”
BackgroundC/EBPα deficiency in podocytes aggravates podocyte senescence and kidney injury in aging mice
Zhang, L., Zhou, F., Yu, X., Zhu, Y., Zhou, Y., Liu, J., Liu, Y., Ma, Q., Zhang, Y., Wang, W., et al. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1933-2 · Cited by 48
Wang, T., Liu, W., Shen, Q., Tao, R., Li, C., Shen, Q., Lin, Y., Huang, Y., Yang, L., Xie, G., et al. (2023) · Cancer Science · doi:10.1111/cas.15961 · Cited by 58
“56,57 Consistent with previous reports, SASP produced by senescent cells disappeared, and cellular senescence was further attenuated after the knockdown of cGAS.”
Immune Alterations with Aging: Mechanisms and Intervention Strategies
Yu, W., Yu, Y., Sun, S., Lu, C., Zhai, J., Lei, Y., Bai, F., Wang, R., & Chen, J. (2024) · Nutrients · doi:10.3390/nu16223830 · Cited by 61
“In 2008, the SASP, also known as the senescence-messaging secretome, was independently characterized by various laboratories as primarily consisting of pro-inflammatory and growth-stimulating proteins [56,57].”
Lineage-Specific Restraint of Pituitary Gonadotroph Cell Adenoma Growth
Chesnokova, V., Zonis, S., Zhou, C., Ben-Shlomo, A., Wawrowsky, K., Toledano, Y., Tong, Y., Kovács, K., Scheithauer, B. W., & Melmed, S. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017924 · Cited by 50
“C/EBPb is associated with oncogene-induced senescence [51], while C/EBPd triggers growth arrest and cell differentiation [43,52,53].”
BackgroundNehlin, J. O., Just, M., Rustan, A. C., & Gaster, M. (2011) · Biogerontology · doi:10.1007/s10522-011-9336-5 · Cited by 66
“Moreover, it has been proposed that senescent cells accumulating in human tissues represent a burden to the tissue since they release a number of factors into their vicinity, affecting other cells in neighbouring tissues, causing the malfunctioning of the particular organ or tissue with time (Coppe ´ et al. 2010; Freu…”
BackgroundEvidence of oncogene-induced senescence in thyroid carcinogenesis
Vizioli, M. G., Possik, P. A., Tarantino, E., Meissl, K., Borrello, M. G., Miranda, C., Anania, M. C., Pagliardini, S., Seregni, E., Pierotti, M. A., et al. (2011) · Endocrine-Related Cancer · doi:10.1530/erc-11-0240 · Cited by 47
Self-citationFrom cellular senescence to age-associated diseases: the miRNA connection
Schraml, E., & Grillari, J. (2012) · Longevity & Healthspan · doi:10.1186/2046-2395-1-10 · Cited by 47
“This includes alteration in gene expression [7], protein secretion [8], and inducibility of apoptosis, which increases in senescent fibroblasts [9] and decreases in endothelial cells [10].”
BackgroundInflammaging, cellular senescence, and cognitive aging after traumatic brain injury
Lu, Y., Jarrahi, A., Moore, N. D., Bartoli, M., Brann, D. W., Baban, B., & Dhandapani, K. M. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106090 · Cited by 54
“SASP consists of increased, cell-dependent secretion of interleukins, cytokines, chemokines, and matrix metalloproteinases to potentiate senescence and perpetuate inflammaging (Coppe et al., 2008; Kuilman and Peeper, 2009).”
Autophagy in cancer: Having your cake and eating it
Hoare, M., Young, A. R. J., & Narita, M. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.09.004 · Cited by 50
Cyclophilin B Supports Myc and Mutant p53-Dependent Survival of Glioblastoma Multiforme Cells
Choi, J. W., Schroeder, M. A., Sarkaria, J. N., & Bram, R. J. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0771 · Cited by 54
“J, cell death induced in U251 cells treated for 48 hours with cyclosporine (CsA), cyclosporine dimer (CsA dimer), or compound 41 (41).”
BackgroundTaschner‐Mandl, S., Schwarz, M., Blaha, J., Kauer, M. O., Kromp, F., Frank, N., Rifatbegovic, F., Weiss, T., Ladenstein, R. L., HOHENEGGER, M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6527 · Cited by 49
“On the other hand, the SASP includes pro-inflammatory cytokines, growth factors and tissue remodeling enzymes that might act as tumor-promoters [19, 25, 26].”
The Role of Extracellular Vesicles in Senescence
Oh, C., Koh, D., Jeon, H. B., & Kim, K. M. (2022) · Molecules and Cells · doi:10.14348/molcells.2022.0056 · Cited by 50
“This characteristic production and secretion pattern in senescent cells is defined as the senescence-associated secretory phenotype (SASP), which affects neighboring cells (Kuilman and Peeper, 2009; Malaquin et al., 2016; Young and Narita, 2009).”
BackgroundChilosi, M., Facchetti, F., Caliò, A., Zamò, A., Brunelli, M., Martignoni, G., Rossi, A., Montagna, L., Piccoli, P., Dubini, A., et al. (2014) · Leukemia & Lymphoma · doi:10.3109/10428194.2014.887713 · Cited by 48
Bunt, J., de Haas, T. G., Hasselt, N. E., Zwijnenburg, D. A., Köster, J., Versteeg, R., & Kool, M. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0546 · Cited by 50
Chung, E. J., McKay-Corkum, G. B., Chung, S. I., White, A. O., Scroggins, B. T., Mitchell, J. B., Mulligan‐Kehoe, M. J., & Citrin, D. E. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.11.044 · Cited by 48
“A number of cytokines and oxidant molecules are elaborated by pneumocytes, stromal cells, and inflammatory cells after irradiation that may contribute to senescence (28-31).”
Rahman, M. M., Islam, F., Mim, S. A., Khan, M. S., Islam, M. R., Haque, M. A., Mitra, S., Emran, T. B., & Rauf, A. (2022) · Journal of Nanomaterials · doi:10.1155/2022/4217529 · Cited by 48
RetractedCellular senescence in neuroinflammatory disease: new therapies for old cells?
Nelke, C., Schroeter, C. B., Pawlitzki, M., Meuth, S. G., & Ruck, T. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.07.003 · Cited by 51
Alexander, E., Hildebrand, D. G., Kriebs, A., Obermayer, K., Manz, M., Rothfuss, O., Essmann, F., & Schulze-Osthoff, K. (2013) · Journal of Cell Science · doi:10.1242/jcs.128835 · Cited by 44
“Although the secretory features of the SASP are probably cell type- and stimulus-specific, IL6 and IL8 have been identified as the most conserved and robustly expressed SASP cytokines (Campisi, 2013; Kuilman and Peeper, 2009).”
BackgroundEffect of Cellular Senescence on the Growth of HER2-Positive Breast Cancers
Zacarias-Fluck, M. F., Morancho, B., Vicario, R., Luque Garcia, A., Escorihuela, M., Villanueva, J., Rubio, I. T., & Arribas, J. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv020 · Cited by 45
Cellular Senescence, Neurological Function, and Redox State
Maciel-Barón, L. Á., Moreno-Blas, D., Morales-Rosales, S. L., González-Puertos, V. Y., López-Díazguerrero, N. E., Torres, C., Castro-Obregón, S., & Königsberg, M. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7112 · Cited by 45
“Another SASP activity is to induce paracrine senescence to neighboring cells (90).”
Extracellular Vesicles: Messengers of p53 in Tumor–Stroma Communication and Cancer Metastasis
Pavlakis, E., Neumann, M. M., & Stiewe, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249648 · Cited by 47
Senescence: Pathogenic Driver in Chronic Obstructive Pulmonary Disease
Rivas, M., Gupta, G., Costanzo, L., Ahmed, H., Wyman, A. E., & Geraghty, P. M. (2022) · Medicina · doi:10.3390/medicina58060817 · Cited by 51
T cell aging as a risk factor for autoimmunity
Liu, Q., Zheng, Y., Goronzy, J. J., & Weyand, C. M. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102947 · Cited by 51
Yang, H., Son, J., Jung, B., Zheng, M., & Kim, J.-R. (2010) · Planta Medica · doi:10.1055/s-0030-1250458 · Cited by 49
Vassilieva, I. O., Kosheverova, V., Vitte, M. A., Kamentseva, R., Shatrova, A. N., Цупкина, Н. В., Skvortsova, E. V., Borodkina, A. V., Tolkunova, E. N., Nikolsky, N. N., et al. (2020) · Aging · doi:10.18632/aging.102737 · Cited by 50
Keeping zombies alive: The ER-mitochondria Ca2+ transfer in cellular senescence
Ahumada-Castro, U., Puebla-Huerta, A., Cuevas-Espinoza, V., Lovy, A., & Cárdenas, C. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119099 · Cited by 47
Immune surveillance of senescent cells in aging and disease
Majewska, J., & Krizhanovsky, V. (2025) · Nature Aging · doi:10.1038/s43587-025-00910-5 · Cited by 57
“Senescent cells are characterized by a protein signature associated with stable cell cycle arrest, metabolic changes, activation of the DNA damage response, resistance to apoptosis and a distinctive secretory phenotype termed the senescence-associated secretory phenotype (SASP) 12,13 .”
Heparan sulfation is essential for the prevention of cellular senescence
Jung, S. H., Lee, H. C., Yu, D.-M., Kim, B., Park, S. M., Lee, Y., Park, H. J., Ko, Y.-G., & Lee, J.-S. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.107 · Cited by 48
“In addition, SASP facilitates tissue repair and remodeling, and elicits immune surveillance to eliminate senescent cells.(11,13,15) Thus, cellular senescence displays multiple effects on the tumor microenvironment of their neighboring tumor and normal cells.”
BackgroundCurcumin and its anti‐colorectal cancer potential: From mechanisms of action to autophagy
Brockmueller, A., de Porras, V. R., & Shakibaei, M. (2024) · Phytotherapy Research · doi:10.1002/ptr.8220 · Cited by 47
“…senescence acting hand in hand with apoptotic as well as autophagic cascades to prevent promotion and progression of neo-plastic cancer cells (Kuilman & Peeper, 2009), it must be clearly distinguished from these cell death mechanisms according to the Nomenclature Committee on Cell Death…”
The NSD2/WHSC1/MMSET methyltransferase prevents cellular senescence‐associated epigenomic remodeling
Tanaka, H., Igata, T., Etoh, K., Koga, T., Takebayashi, S., & Nakao, M. (2020) · Aging Cell · doi:10.1111/acel.13173 · Cited by 41
“…in mouse and human (Dimri et al., 1995; Jeyapalan & Sedivy, 2008) and cause tissue dysfunction at least in part through a proinflammatory program referred to as the senescence-associated secretory phenotype (SASP) or senescence-messaging secretome (Coppé et al., 2008; Kuilman & Peeper, 2009).”
BackgroundHMGB1 orchestrates STING-mediated senescence via TRIM30α modulation in cancer cells
Lee, J., Park, I. H., Kwak, M. S., Rhee, W. J., Kim, S. H., & Shin, J. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00409-z · Cited by 43
Cellular senescence in liver diseases: From molecular drivers to therapeutic targeting
Du, K., Umbaugh, D. S., Ren, N., & Diehl, A. M. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.08.021 · Cited by 48
Kunimasa, K., Nagano, T., Shimono, Y., Dokuni, R., Kiriu, T., Tokunaga, S., Tamura, D., Yamamoto, M., TACHIHARA, M. Y., Kobayashi, K., et al. (2017) · Cancer Science · doi:10.1111/cas.13266 · Cited by 44
Urea-induced ROS accelerate senescence in endothelial progenitor cells
D’Apolito, M., Colia, A. L., Lasalvia, M., Capozzi, V., Falcone, M. P., Pettoello‐Mantovani, M., Brownlee, M., Maffione, A. B., & Giardino, I. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.06.028 · Cited by 45
Amemiya, Y., Yang, W., Benatar, T., Nofech‐Mozes, S., Yee, A., Kahn, H. K., Holloway, C. M. B., & Seth, A. K. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0921-0 · Cited by 45
“In melanoma cells, IGFBP-7 strongly suppresses the phosphorylation of ERK, a downstream mediator of MAPK signaling, suggesting that IGFBP-7 mediates its anti-proliferative effects through negative feedback signaling [3].”
BackgroundCellular senescence in liver fibrosis: Implications for age-related chronic liver diseases
Udomsinprasert, W., Sobhonslidsuk, A., Jittikoon, J., Honsawek, S., & Chaikledkaew, U. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1992385 · Cited by 40
“Senescent cells, in turn, can alter DNA methylation signatures and also produce a wide range of cytokines and growth factors into the cell microenvironment, as well as a number of soluble and insoluble molecules, a phenomenon known as the SASP [27,28].”
BackgroundClerico, A., Zaninotto, M., Aimo, A., Cardinale, D. M., Dittadi, R., Sandri, M. T., Perrone, M. A., Belloni, L., Fortunato, A., Trenti, T., et al. (2023) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2022-1285 · Cited by 43
The serine protease inhibitor serpinB2 binds and stabilizes p21 in senescent cells
Hsieh, H.-H., Chen, Y., Jhan, J.-R., & Lin, J. (2017) · Journal of Cell Science · doi:10.1242/jcs.204974 · Cited by 45
“In addition to this specific microscopic phenotype, senescent cells also have alterations in gene expression, microRNA expression and protein secretion (Acosta et al., 2008; Campisi and d’Adda di Fagagna, 2007; Chen et al., 2004; Grillari and Grillari-Voglauer, 2010; Kuilman et al., 2008; Kuilman and Peeper, 2009; Zha…”
BackgroundMikuriya, Y., Tashiro, H., Kuroda, S., Nambu, J., Kobayashi, T., Amano, H., Tanaka, Y., & Ohdan, H. (2014) · International Journal of Cancer · doi:10.1002/ijc.29096 · Cited by 39
Myeloma cells can corrupt senescent mesenchymal stromal cells and impair their anti-tumor activity
Özcan, S., Alessio, N., Acar, M. B., Toprak, G., Gönen, Z. B., Peluso, G., & Galderisi, U. (2015) · Oncotarget · doi:10.18632/oncotarget.5430 · Cited by 43
“The secretome of senescent cells can also contain numerous inflammatory cytokines, growth factors, and proteases that can render the tissue microenvironment favorable for tumor growth, since some tumor cells misuse SASP for their own growth [2, 5, 6].”
BackgroundThe Role of STAT3 in Thyroid Cancer
Sosonkina, N., Starenki, D., & Park, J. (2014) · Cancers · doi:10.3390/cancers6010526 · Cited by 44
“It has been reported that cells undergoing Ras/Raf-induced senescence secrete soluble factors that can help reinforce senescence-like growth arrest responses [113,114].”
BackgroundThe adenoma hunt in colorectal cancer screening: defining the target
Sillars-Hardebol, A. H., Carvalho, B. G., van Engeland, M., Fijneman, R. J. A., & Meijer, G. A. (2011) · The Journal of Pathology · doi:10.1002/path.3012 · Cited by 42
“Overcoming senescence is therefore a crucial progression step in malignant transformation, during which stabilization of telomeres (mainly by activation of hTERT ), a defective DNA damage response (caused by mutations in genes such as ATM, and due to activity loss of the Rb and p53 pathway effectors) and interference…”
BackgroundCPEB Control of NF-κB Nuclear Localization and Interleukin-6 Production Mediates Cellular Senescence
Groppo, R., & Richter, J. D. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05133-11 · Cited by 39
“High levels of these secreted factors may also recruit immune cells to the site of senescent cells, helping to clear them and prevent tumor formation (2, 7, 26).”
BackgroundA Model for p38MAPK-Induced Astrocyte Senescence
Mombach, J. C. M., Vendrusculo, B., & Bugs, C. A. (2015) · PLOS ONE · doi:10.1371/journal.pone.0125217 · Cited by 38
“The model predicts enhanced senescence for GoF of p16INK4a maintained at its state 2 and loss of senescence for its LoF, compatible with observations in other cell types [4].”
ResultFOXQ1 regulates senescence-associated inflammation via activation of SIRT1 expression
Wang, P., Lv, C., Zhang, T., Liu, J., Yang, J., Guan, F., & Hong, T. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.340 · Cited by 43
“There is mounting evidence that senescent cells, which often persist in vivo, can promote tumor progression in addition to other age-related pathologies via the senescence-associated secretory phenotype (SASP).(7,8) Senescent cells can secret numerous kinds of pro-inflammatory cytokines, chemokines, growth factors and…”
BackgroundPathways from senescence to melanoma: focus on MITF sumoylation
Leclerc, J., Ballotti, R., & Bertolotto, C. (2017) · Oncogene · doi:10.1038/onc.2017.292 · Cited by 46
G Protein-Coupled Receptor Systems as Crucial Regulators of DNA Damage Response Processes
Leysen, H., van Gastel, J., Hendrickx, J. O., Santos‐Otte, P., Martin, B., & Maudsley, S. R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102919 · Cited by 39
“SASP responses, like cell cycle arrest events, can also be dependent on protracted DNA damage signaling [143], caused by the feed-forward loops that can be generated between DDR signaling and ROS attack [144].”
BackgroundInfluentialInsulin-like growth factor binding protein-6 delays replicative senescence of human fibroblasts
Micutkova, L., Diener, T., Li, C., Rogowska-Wrzesinska, A., Mueck, C., Huetter, E., Weinberger, B., Grubeck-Loebenstein, B., Roepstorff, P., Zeng, R., et al. (2011) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2011.07.005 · Cited by 39
Are aging biomarkers clinically relevant in oncogeriatrics?
Falandry, C., Gilson, É., & Rudolph, K. L. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2012.08.004 · Cited by 44
“[50] Kuilman T, Peeper DS.”
Cellular senescence in ischemia/reperfusion injury
Chen, C., Zheng, M., Hou, H., Fang, S., Chen, L., Yang, J., Yao, W., Zhang, Q., & Hei, Z. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01205-z · Cited by 44
The Emerging Role of Senotherapy in Cancer: A Comprehensive Review
Malayaperumal, S., Marotta, F., Kumar, M. M., Somasundaram, I., Ayala, A., Pinto, M. F. M., Banerjee, A., & Pathak, S. (2023) · Clinics and Practice · doi:10.3390/clinpract13040076 · Cited by 41
“Secretory phenotype cells are not limited to the cell-cycle arrest, but are metabolically active cells that have changed protein expression and secretion [4].”
BackgroundGleason, C. E., Dickson, M. A., Klein, M. E., Antonescu, C. R., Gularte‐Mérida, R., Benitez, M., Delgado, J. I., Kataru, R. P., Tan, M. W. Y., Bradić, M., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-2378 · Cited by 43
Metadata
- Authors
- Kuilman, T., & Peeper, D. S.
- Affiliations
- The Netherlands Cancer Institute (NL)
- Corresponding author
- Peeper, Daniel S.
- Venue
- Nature Reviews Cancer
- Published
- 2009-01-09
- Volume
- 9
- Issue
- 2
- Pages
- 81-94
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2005248738
- Cited by
- 909
- References
- 146
- Citations by year
- 2026: 25 · 2025: 46 · 2024: 46 · 2023: 48 · 2022: 54 · 2021: 73 · 2020: 62 · 2019: 43 · 2018: 63 · 2017: 56 · 2016: 60 · 2015: 53 · 2014: 68 · 2013: 55 · 2012: 47
- FWCI
- 5.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- KWF Kankerbestrijding
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- secreted factors, senescence-associated secretory phenotype, cancer protection
- MeSH terms
- Animals, Cell Communication, Humans, Neoplasms, Signal Transduction, Cellular Senescence, Tumor Suppressor Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.